We split the data into two groups according to the median level of KRAS and observed that some important signatures (EMT, apoptosis, and TNFα/NFκB signaling) and immune cell infiltration were inclusively enriched in the KRAS-high vs KRAS-low datasets in these cancers. The gene discussed is KRAS; the disease is cancer.